Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines
MIT researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells, providing a new approach to developing and implementing antigen-presenting cell vaccines.
Such vaccines, created by reprogramming a patient’s own immune cells to fight invaders, hold great promise for treating cancer and other diseases. However, several inefficiencies have limited their translation to the clinic, and only one therapy has been approved by the Food and Drug Administration.
While most of these vaccines are created with dendritic cells, a class of antigen-presenting cells with broad functionality in the immune system, the researchers demonstrate in a study published in Scientific Reports that B cells can be engineered to serve as an alternative.
“We wanted to remove an important barrier in using B cells as an antigen-presenting cell population, helping them complement or replace dendritic cells,” says Gregory Szeto, a postdoc at MIT’s Koch Institute for Integrative Cancer Research and the paper’s lead author.
Darrell Irvine, a member of the Koch Institute and a professor of biological engineering and of materials sciences and engineering, is the paper’s senior author.
A new vaccine-preparation approach
Dendritic cells are the most naturally versatile antigen-presenting cells. In the body, they continuously sample antigens from potential invaders, which they process and present on their cell surface. The cells then migrate to the spleen or the lymph nodes, where they prime T cells to mount an attack against cells that are cancerous or infected, targeting the specific antigens that are ingested and presented.
Despite their critical role in the immune system, dendritic cells have drawbacks when used for cell-based vaccines: They have a short lifespan, they do not divide when activated, and they are relatively sparse in the bloodstream.
B cells are also antigen-presenting cells, but in contrast to dendritic cells, they can proliferate when activated and are abundant in the bloodstream. However, their functionality is more limited: Whereas dendritic cells constantly sample antigens they encounter, a B cell is genetically programmed only to bind to a specific antigen that matches the receptor on its surface. As such, a B cell generally will not ingest and display an antigen if it does not match its receptor.
Using a microfluidic device, MIT researchers were able to overcome this genetically programmed barrier to antigen uptake — by squeezing the B cells.
Through “CellSqueeze,” the device platform originally developed at MIT, the researchers pass a suspension of B cells and target antigen through tiny, parallel channels etched on a chip. A positive-pressure system moves the suspension through these channels, which gradually narrow, applying a gentle pressure to the B cells. This “squeeze” opens small, temporary holes in their membranes, allowing the target antigen to enter by diffusion.
This process effectively loads the cells with antigens to prime a response of CD8 — or “killer” — T cells, which can then kill cancer cells or other target cells.
Read more: Freshly squeezed vaccines
The Latest on: Cell-based vaccines
via Google News
The Latest on: Cell-based vaccines
- Project Veritas reignites debunked aborted fetal cell COVID vaccine theoryon October 11, 2021 at 8:35 am
In this week's conspiracy theory newsletter, we look at how Project Veritas reignited a debunked aborted fetal cell COVID vaccine theory.
- Malaria vaccine is a major leap forward: but innovation mustn’t stop hereon October 11, 2021 at 8:06 am
The successful development of an effective vaccine against the deadliest form of malaria that is most common in sub-Saharan Africa is indeed a major achievement.
- CLSN: Initiating Coverage of Celsion Corporation; Novel DNA-Based Cancer Immunotherapy Technology…on October 11, 2021 at 7:44 am
CLSN READ THE FULL CLSN RESEARCH REPORT Initiating Coverage We are initiating coverage of Celsion Corporation (NASDAQ:CLSN) with a valuation of $3.50. Celsion is a biopharmaceutical company developing ...
- Uneven Covid-19 vaccine efficacy in blood cancers mean masks to stayon October 11, 2021 at 6:08 am
A quarter of haematological cancer patients do not mount an effective immune response after Covid-19 vaccination. B-cell directed therapies make vaccine efficacy variable depending on cancer subtype ...
- Vaccine-induced memory B cells can recognize SARS-CoV-2 variantson October 11, 2021 at 2:17 am
Researchers have been investigating the effect that memory B cells produced in individuals who have received an mRNA vaccine have against SARS-CoV-2 variants.
- Local clergy agree: No religious exemptions for COVID vaccine | Faith Matterson October 10, 2021 at 5:00 am
Vaccines are a modern medical practice and the holy books that inspire all the major religions were compiled ages ago.
- Is my immunity waning? Doctors advise Pfizer vaccine recipients not to worryon October 9, 2021 at 6:29 am
That's why Pfizer has asked for and received US Food and Drug Administration authorization to add boosters for many people who are six months out from vaccination. "I think that we expect that ...
- Does Pfizer’s COVID-19 Vaccine Contain Aborted Fetal Cells?on October 8, 2021 at 9:24 am
In October 2021, a number of social media users started spreading the claim that Pfizer’s COVID-19 vaccine contained aborted fetal cells. There are no aborted fetal cells in Pfizer’s COVID-19 vaccine.
- Woman Rejects Vaccine as Christian, Refused Life-Saving Kidney Transplanton October 8, 2021 at 8:13 am
Leilani Lutali, a born-again Christian, decided to reject taking the COVID-19 vaccine based on her faith, but is facing a huge conundrum now she's found that her local hospital won't approve her ...
- Are Christians allowed to invest in companies which use stem cells in vaccine development?on October 4, 2021 at 10:03 am
Much of our society is based on idolatry, evil, theft, murder. But our calling has always been to refrain from sin, not refrain from society.
via Bing News